mephentermine has been researched along with Heart Defects, Congenital in 2 studies
Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WALDMAN, S | 1 |
| PELNER, L | 1 |
| Rautenberg, HW | 1 |
2 other studies available for mephentermine and Heart Defects, Congenital
| Article | Year |
|---|---|
Mephentermine sulfate and meprobamate in treatment of angina pectoris due to aortic valvular disease.
Topics: Angina Pectoris; Aortic Valve; Bicuspid Aortic Valve Disease; Disease; Heart Defects, Congenital; He | 1961 |
[Pharmacodynamic phonocardiography].
Topics: Adult; Amyl Nitrite; Antihypertensive Agents; Catechols; Child; Diagnosis, Differential; Epinephrine | 1969 |